Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Certain genetic variants correlate with heightened nausea sensitivity or slower gastric emptying, allowing your provider to start at a gentler dose or extend your dose escalation schedule
Any references to biochemical pathways, receptor interactions, or enzymatic processes are provided solely for informational and research-context purposes
Common side effects reported in clinical trials include: Nausea (experienced by about 20% of patients) Vomiting (reported in 9% of patients) Diarrhea (affects approximately 8% of users) Stomach pain Decreased appetite These side effects typically improve as the body adjusts to the medication, usually within a few weeks
This dual formulation combines BPC-157 and TB-500 peptide blend in a single, lab-grade injectable format with third-party testing and Certificate of Analysis (COA) verification
